Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2019-10-31 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice from Sanofi informing stock exchanges about an upcoming Board of Directors meeting scheduled for November 12, 2019. The purpose of the meeting is to consider unaudited financial results for the quarter and nine months ended September 30, 2019. The document is brief (1163 characters) and serves as an announcement of a future event rather than containing any financial data or detailed report. It does not include actual financial statements or detailed analysis, nor does it present the results themselves. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER). It is a regulatory announcement about a board meeting related to financial results, which fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document. The confidence in this classification is high due to the clear nature and content of the document.
2019-10-31 English
Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the ....
Regulatory Filings Classification · 95% confidence The document is a short notification (under 5,000 characters) informing the stock exchanges about an upcoming Board of Directors meeting to consider financial results. It does not contain the financial results themselves, but rather announces the date of the meeting. Therefore, it falls under the category of a regulatory filing/announcement regarding corporate events.
2019-10-31 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss reporting. The content is a notification to the exchanges to take the information on record. There is no financial data, no report attached or referenced, no management or board changes, no voting results, no earnings or capital updates. This is a regulatory compliance announcement related to share certificate loss, which does not fit into specific report categories but is a regulatory filing. The document length is short (1339 characters), and it is an announcement rather than a report itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-10-30 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the loss of share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, which pertains to share certificate loss reporting. The content is an announcement of an event related to share certificates, not a financial report, management discussion, or any other detailed report. The document length is short (1368 characters) and it serves as an official notification to the exchanges. This fits the category of a Regulatory Filing (RNS), as it is a general regulatory announcement that does not fit into more specific categories like share issue or director dealings.
2019-10-22 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the loss of share certificates, citing SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. It provides details of the lost share certificates and requests the exchanges to take the information on record. The content is a regulatory notification about share certificate loss, not a financial report, earnings release, or management information. It does not contain financial data or detailed report content. This type of filing is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2019-10-17 English
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the period 1st April 2019 ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It confirms the maintenance of share transfer facilities for a specified period. The document is short (2340 characters) and serves as a regulatory compliance confirmation rather than a financial report or detailed filing. It does not contain financial statements or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and regulatory announcements.
2019-10-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.